Witter Malcolm G
- SEC CIK
- 0001838283
No open-market purchases or sales filed in the past year.
Current role at each company
- NAVB Navidea Biopharmaceuticals, Inc.Directoras of Nov 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Witter Malcolm G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 (view filing) | Aug 30 | 2 days | Witter Malcolm GDirector | PPurchase | +511.1K | – | – | –115 after | Derivative2 lots |
| Sep 17, 2021 (view filing) | Sep 17 | Same day | Witter Malcolm GDirector | PPurchase | +20.0K | $1.60 | +$32.0K | +25.6%98.3K after | |
| Jul 26, 2021 (view filing) | Jul 26 | Same day | Witter Malcolm GDirector | PPurchase | +15.0K | $1.70 | +$25.5K | +23.7%78.3K after |